Frank A. Holtkamp

869 total citations
9 papers, 574 citations indexed

About

Frank A. Holtkamp is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Nephrology. According to data from OpenAlex, Frank A. Holtkamp has authored 9 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 3 papers in Surgery and 3 papers in Nephrology. Recurrent topics in Frank A. Holtkamp's work include Blood Pressure and Hypertension Studies (5 papers), Chronic Kidney Disease and Diabetes (3 papers) and Cardiac electrophysiology and arrhythmias (2 papers). Frank A. Holtkamp is often cited by papers focused on Blood Pressure and Hypertension Studies (5 papers), Chronic Kidney Disease and Diabetes (3 papers) and Cardiac electrophysiology and arrhythmias (2 papers). Frank A. Holtkamp collaborates with scholars based in Netherlands, Australia and Denmark. Frank A. Holtkamp's co-authors include Hiddo J.L. Heerspink, Dick de Zeeuw, Pieter A. de Graeff, Julia B. Lewis, Barry M. Brenner, Shahnaz Shahinfar, Hans Hillege, Hans‐Henrik Parving, Merlin C. Thomas and Mark E. Cooper and has published in prestigious journals such as Diabetes Care, Kidney International and European Heart Journal.

In The Last Decade

Frank A. Holtkamp

9 papers receiving 559 citations

Peers

Countries citing papers authored by Frank A. Holtkamp

Since Specialization

Citations

This map shows the geographic impact of Frank A. Holtkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank A. Holtkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank A. Holtkamp more than expected).

Fields of papers citing papers by Frank A. Holtkamp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank A. Holtkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank A. Holtkamp. The network helps show where Frank A. Holtkamp may publish in the future.

Co-authorship network of co-authors of Frank A. Holtkamp

This figure shows the co-authorship network connecting the top 25 collaborators of Frank A. Holtkamp. A scholar is included among the top collaborators of Frank A. Holtkamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank A. Holtkamp. Frank A. Holtkamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Individual long-term albuminuria exposure during angiotensin receptor blocker therapy is the optimal predictor for renal outcome 2016 ·Nephrology Dialysis Transplantation ·(unknown), Dick de Zeeuw, Frank A. Holtkamp, David Packham, Hiddo J.L. Heerspink	13
2	CardioPulse ArticlesThe European Medicines Agency's approval of proprotein convertase subtilisin/kexin type 9 inhibitorsLeaders in cardiovascular medicine of todayProfessor David Wood, Imperial College, LondonPrevention of global cardiovascular diseaseThe plunging mortality of cardiovascular disease in IsraelBook reviewEuropean Society of Cardiology textbook of preventive cardiology 2016 ·European Heart Journal ·E. Blind, Pieter A. de Graeff, Illiana Meurs, Frank A. Holtkamp, (unknown), Heidi Janssen	1
3	The European Medicines Agency's approval of proprotein convertase subtilisin/kexin type 9 inhibitors 2015 ·European Heart Journal ·E. Blind, Pieter A. de Graeff, Illiana Meurs, Frank A. Holtkamp, (unknown), Heidi Janssen	2
4	Safety information on QT-interval prolongation: comparison of European Union and United States drug labeling 2014 ·Drug Discovery Today ·(unknown), Frank A. Holtkamp, Frans H. Rutten, Arno W. Hoes, Anthonius de Boer, Peter G. M. Mol, Marie L. De Bruin	5
5	Quality of drug label information on QT interval prolongation 2014 ·International Journal of Risk & Safety in Medicine ·(unknown), Frank A. Holtkamp, Frans H. Rutten, Arno W. Hoes, Anthonius de Boer, Peter G. M. Mol, Marie L. De Bruin	6
6	Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers 2012 ·Kidney International ·Hiddo J.L. Heerspink, Frank A. Holtkamp, Hans‐Henrik Parving, Gerjan Navis, Julia B. Lewis, Eberhard Ritz, Pieter A. de Graeff, Dick de Zeeuw	176
7	An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function 2011 ·Kidney International ·Frank A. Holtkamp, Dick de Zeeuw, Merlin C. Thomas, Mark E. Cooper, Pieter A. de Graeff, Hans Hillege, Hans‐Henrik Parving, Barry M. Brenner, Shahnaz Shahinfar, Hiddo J.L. Heerspink	243
8	Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials 2011 ·European Heart Journal ·Frank A. Holtkamp, Dick de Zeeuw, P. A. de Graeff, Gozewijn D. Laverman, Tomás Berl, Giuseppe Remuzzi, David Packham, Julia B. Lewis, H.‐H. Parving, Hiddo J.L. Heerspink	95
9	Monitoring Kidney Function and Albuminuria in Patients With Diabetes 2011 ·Diabetes Care ·Hiddo J.L. Heerspink, Frank A. Holtkamp, Dick de Zeeuw, Mordchai Ravid	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact